Capital Flow Monitor · Sponsors · CIK 1741495
Vergent Bioscience, Inc.
5810 W 78TH ST, MINNEAPOLIS, MN, 55439 · 9524263772
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$32.0M
Sold
$18.7M
% sold
58.4%
Investors
20
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-20 | D ·current | 506(b) | $32.0M | $18.7M | 58.4% | 20 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- John T. Santini, Jr. — Executive Officer / Director, Minneapolis, MN
-
Douglas Kohrs — Director, Minneapolis, MN
2 other raises
- Osteal Therapeutics, Inc. $15.6M of $26.7M · 58.4%
- RESTOR3D, Inc. $84.8M of $94.8M · 89.5%
-
Raymond Wong — Director, Minneapolis, MN
2 other raises
- ShowdMe, Inc. $2.0M of $2.0M · 100.0%
- Cheetah Korea Value Fund $11.3M of —
- Bobby Helmedag — Director, Minneapolis, MN
- Anita Watkins — Director, Minneapolis, MN
- Jeffrey Yurecko — Executive Officer, Minneapolis, MN
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.